经动脉化疗栓塞及肝恶性肿瘤栓塞的质量改进指南 - Suppr

Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy.

作者信息

Gaba Ron C, Lokken R Peter, Hickey Ryan M, Lipnik Andrew J, Lewandowski Robert J, Salem Riad, Brown Daniel B, Walker T Gregory, Silberzweig James E, Baerlocher Mark Otto, Echenique Ana Maria, Midia Mehran, Mitchell Jason W, Padia Siddharth A, Ganguli Suvranu, Ward Thomas J, Weinstein Jeffrey L, Nikolic Boris, Dariushnia Sean R

机构信息

Division of Interventional Radiology, Department of Radiology, University of Illinois Hospital & Health Sciences System, 1740 West Taylor Street, MC 931, Chicago, IL 60612.

出版信息

J Vasc Interv Radiol. 2017 Sep;28(9):1210-1223.e3. doi: 10.1016/j.jvir.2017.04.025. Epub 2017 Jun 29.

DOI:10.1016/j.jvir.2017.04.025

PMID:28669744

Abstract

摘要

相似文献

Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy.

J Vasc Interv Radiol. 2017 Sep;28(9):1210-1223.e3. doi: 10.1016/j.jvir.2017.04.025. Epub 2017 Jun 29.

Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.

J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):225-32. doi: 10.1097/01.RVI.0000195330.47954.48.

Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.

J Vasc Interv Radiol. 2012 Mar;23(3):287-94. doi: 10.1016/j.jvir.2011.11.029. Epub 2012 Jan 30.

Quality-improvement guidelines for hepatic transarterial chemoembolization.

Cardiovasc Intervent Radiol. 2012 Aug;35(4):765-74. doi: 10.1007/s00270-012-0423-z. Epub 2012 May 31.

Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.

J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):217-23. doi: 10.1097/01.RVI.0000196277.76812.A3.

Re: Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.

J Vasc Interv Radiol. 2006 Jul;17(7):1209; author reply 1209-10. doi: 10.1097/01.RVI.0000223714.14073.44.

Transarterial chemoembolization for hepatocellular carcinoma.

J Am Coll Surg. 2006 Jan;202(1):155-68. doi: 10.1016/j.jamcollsurg.2005.06.263. Epub 2005 Oct 19.

Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome.

J Vasc Interv Radiol. 2016 Sep;27(9):1269-1278. doi: 10.1016/j.jvir.2016.04.014. Epub 2016 Jun 24.

Transarterial chemoembolisation is not superior to embolisation alone: the recent European Association for the Study of the Liver (EASL) - European Organisation for Research and Treatment of Cancer (EORTC) guidelines.

Eur J Cancer. 2013 Apr;49(6):1509-10. doi: 10.1016/j.ejca.2012.11.012. Epub 2012 Dec 8.

Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.

Surg Oncol Clin N Am. 2015 Jan;24(1):149-66. doi: 10.1016/j.soc.2014.09.004. Epub 2014 Oct 7.

引用本文的文献

Transarterial chemoembolization plus lenvatinib with or without protein-1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombus.

World J Clin Oncol. 2025 Jun 24;16(6):106798. doi: 10.5306/wjco.v16.i6.106798.

Transarterial Chemoembolization: A Consistent and Continuously Evolving Therapy for Hepatocellular Carcinoma.

J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102538. doi: 10.1016/j.jceh.2025.102538. Epub 2025 Mar 3.

Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group.

Eur J Nucl Med Mol Imaging. 2025 Mar 28. doi: 10.1007/s00259-025-07229-8.

Model Predicting Survival in Intermediate-Stage HCC Patients Reclassified for TACE Based on the 2022 BCLC Criteria.

Cancers (Basel). 2025 Mar 5;17(5):894. doi: 10.3390/cancers17050894.

Locoregional Therapies for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.

Biomedicines. 2024 Sep 30;12(10):2226. doi: 10.3390/biomedicines12102226.

Adverse Event Rates in Interventional Radiology: A Review of 30 Years of Societal Quality Improvement Publications.

Cardiovasc Intervent Radiol. 2024 Dec;47(12):1687-1693. doi: 10.1007/s00270-024-03859-x. Epub 2024 Sep 30.

Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review.

Front Oncol. 2024 Aug 23;14:1464242. doi: 10.3389/fonc.2024.1464242. eCollection 2024.

Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma.

Pharmaceuticals (Basel). 2024 Aug 11;17(8):1057. doi: 10.3390/ph17081057.

Drug-eluting bead transarterial chemoembolization combined with apatinib/camrelizumab for the treatment of advanced hepatocellular carcinoma with hepatic arterioportal shunts.

Br J Radiol. 2024 Dec 1;97(1164):1925-1930. doi: 10.1093/bjr/tqae166.

Efficacy and Safety of TACE Combined with Regorafenib versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma With Untreatable Progression After TACE Combined with Sorafenib Therapy: A Case Control Study.

Cancer Control. 2024 Jan-Dec;31:10732748241275004. doi: 10.1177/10732748241275004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献